Endoscopy 2018; 50(04): S68-S69
DOI: 10.1055/s-0038-1637230
ESGE Days 2018 oral presentations
21.04.2018 – ERCP 3: Hot topics and post liver transplantation
Georg Thieme Verlag KG Stuttgart · New York

ENDOSCOPIC PAPILLECTOMY: LONG TERM RESULTS IN 110 CONSECUTIVE PATIENTS

G Valerii
1   Catholic University of Rome, Digestive Endoscopy Unit, Rome, Italy
,
A Tringali
1   Catholic University of Rome, Digestive Endoscopy Unit, Rome, Italy
,
V Bove
1   Catholic University of Rome, Digestive Endoscopy Unit, Rome, Italy
,
R Landi
1   Catholic University of Rome, Digestive Endoscopy Unit, Rome, Italy
,
F Barbaro
1   Catholic University of Rome, Digestive Endoscopy Unit, Rome, Italy
,
I Boškoski
1   Catholic University of Rome, Digestive Endoscopy Unit, Rome, Italy
,
P Familiari
1   Catholic University of Rome, Digestive Endoscopy Unit, Rome, Italy
,
V Perri
1   Catholic University of Rome, Digestive Endoscopy Unit, Rome, Italy
,
G Costamagna
1   Catholic University of Rome, Digestive Endoscopy Unit, Rome, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
27 March 2018 (online)

Also available at
 
 

    Aims:

    Ampullary adenomas represents 5% of the neoplasia of the gastrointestinal tract with a premalignant nature. Aim of this study is to evaluate the results and the long-term follow-up of endoscopic papillectomy (EP) of adenoma of the ampulla of Vater.

    Methods:

    Consecutive patients undergoing EP between May 2000 and October 2017.

    The following data were recorded: size of the ampullary lesion, pre- and post-EP histology, complications, local recurrence rate and survival. Endoscopic follow-up was scheduled after 1, 3, 6 and 12 months for the first year, and then yearly for the following 5 years.

    Results:

    EP was performed in 110 consecutive patients (61 F, mean age 59.2). 77.3% en-bloc resection, 22.7% piecemeal. 28 patients (25.4%) had familiar adenomatous polyposis (FAP).

    Biliary sphincterotomy with or without insertion of a plastic stent was performed after EP in 77 patient (70%).

    Histopatological findings are summarized in table 1.

    Tab. 1:

    Endoscopic papillectomy: histopatological results

    Low Grade Dysplasia, n (%)

    27 (24.5)

    High Grade Dysplasia, n (%)

    36 (32.7)

    High Grade Dysplasia + focal Adenocarcinoma, n (%)

    17 (15.4)

    Intramucosal Adenocarcinoma, n (%)

    24 (22.0)

    Neuroendocrine tumor, n (%)

    6 (5.4)

    Delayed bleeding was reported in 19 patients (17.3%) treated endoscopically, except in 1 case.

    Retroperitoneal perforations occurred in 3/110 (2.7%) cases and were successfully treated by surgical (n = 2) or percutaneous (n = 1) drainage.

    Regular follow-up was available in 94/110 patients (85.4%), mean 31.6 months (range 1 – 108).

    Residual and recurrent adenomas were diagnosed in 28 (29.8%) and 19 (20.2%) cases, respectively and were successfully retreated endoscopically except in 4 cases treated by surgery.

    Nine patients (8.2%) with adenocarcinoma on final histology, were referred to surgery.

    Conclusions:

    EP is effective with favorable long-term outcomes avoiding invasive surgical procedures. The high incidence of residual/recurrent adenoma is balanced by the successful endoscopic re-treatment.


    #